Pharmaceutical Nanotechnology

Non-Viral Engineering of CAR-T Cells Using RNA Nanoparticles for Glioblastoma Immunotherapy

Queen's University Belfast

School of Pharmacy

Location
Belfast, United Kingdom
Funding
Funded Studentship
Application deadline
See university guidance

About the project

  • Share Facebook Twitter Linkedin Email
  • Facebook
  • Twitter
  • Linkedin
  • Email
  • Postgraduate Research 2026
  • PhD Opportunities
  • Find a PhD Supervisor

Non-Viral Engineering of CAR-T Cells Using RNA Nanoparticles for Glioblastoma Immunotherapy

  • Non-Viral Engineering of CAR-T Cells Using RNA Nanoparticles for Glioblastoma Immunotherapy: School of Pharmacy | PHD
  • Project details
  • Subject information
  • Course content
  • Entry Requirements
  • Fees and Funding
  • Apply

Overview

Glioblastoma (GBM) is the most aggressive primary brain tumour in adults, characterised by rapid progression, extensive cellular heterogeneity and a highly immunosuppressive tumour microenvironment. Despite advances in surgery, radiotherapy and chemotherapy, patient prognosis remains poor, highlighting the urgent need for innovative therapeutic strategies. Chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment of certain haematological malignancies, but its application to solid tumours, particularly GBM, remains challenging due to limited T-cell infiltration, tumour heterogeneity and an immunosuppressive microenvironment. Conventional CAR-T cell therapies rely on the ex vivo genetic modification and expansion of patient-derived T cells, requiring complex, time-consuming and expensive manufacturing procedures. Non-viral RNA-based technologies offer an exciting alternative by enabling transient CAR expression without permanent genetic modification. In particular, self-amplifying RNA (saRNA) can sustain therapeutic protein expression at relatively low RNA doses, offering opportunities to improve the duration and efficiency of T-cell engineering. This PhD project aims to develop innovative polymeric and lipid-polymer hybrid nanoparticles for the non-viral delivery of CAR-encoding saRNA to T cells, with the ultimate goal of establishing a new strategy for GBM immunotherapy. Particular emphasis will be placed on engineering nanoparticles capable of efficiently targeting T cells while preserving their viability and antitumour functionality. The main objectives of this PhD project are: - Objective 1 – Nanoparticle engineering: Design, formulate and characterise polymeric and lipid-polymer hybrid nanoparticles for the encapsulation and delivery of CAR-encoding saRNA. - Objective 2 – Non-viral T-cell engineering: Investigate nanoparticle-mediated saRNA delivery to human T cells, evaluating transfection efficiency, CAR expression kinetics, cellular viability and T-cell phenotype. - Objective 3 – Functional evaluation of engineered CAR-T cells: Assess the antitumour activity of saRNA-engineered CAR-T cells against GD2-expressing glioblastoma cells using advanced in vitro and three-dimensional tumour models. - Objective 4 – Towards in vivo CAR-T cell engineering: Explore strategies for T-cell-targeted nanoparticle delivery and evaluate their potential to support CAR-T cell generation in situ, subject to experimental feasibility and appropriate model development. The project will integrate expertise in pharmaceutical nanotechnology, RNA therapeutics, molecular and cellular biology, and cancer immunotherapy. By combining advanced nanoparticle engineering with emerging RNA technologies, this research seeks to address important limitations of conventional CAR-T cell manufacturing and contribute to the development of more accessible and adaptable immunotherapies for brain cancer. The successful candidate will join a multidisciplinary research environment within the School of Pharmacy at Queen's University Belfast, contributing to an emerging research programme focused on RNA nanomedicine and non-viral immune cell engineering.

The successful candidate will receive comprehensive multidisciplinary training at the interface of pharmaceutical nanotechnology, RNA therapeutics, molecular biology and cancer immunotherapy. The project will provide an excellent opportunity to acquire expertise in emerging non-viral gene delivery technologies and their application to the development of innovative cancer treatments. The student will receive hands-on training in the design, formulation and physicochemical characterisation of polymeric and lipid-polymer hybrid nanoparticles, including nanoparticle preparation, RNA encapsulation, dynamic light scattering, surface charge analysis and electron microscopy. Training will also cover the handling and characterisation of self-amplifying RNA, alongside the optimisation of nanoparticle-mediated RNA delivery. Advanced cellular and molecular biology training will include mammalian cell culture, primary human T-cell isolation and activation, flow cytometry, fluorescence microscopy, gene and protein expression analysis, and functional assays to evaluate CAR-T cell activity. The student will also gain experience in establishing and using 3D glioblastoma models to investigate therapeutic efficacy in physiologically relevant experimental systems. Depending on project progression and relevant approvals, opportunities may also be available to gain exposure to preclinical models of glioblastoma and in vivo RNA delivery. In addition to technical expertise, the student will develop transferable skills in experimental design, critical analysis, scientific writing, research ethics, data management and scientific communication. They will be encouraged to present their findings at national and international conferences, contribute to peer-reviewed publications and engage in interdisciplinary collaborations. The training programme will support the development of an independent researcher equipped with highly relevant skills for future careers in academia, pharmaceutical biotechnology and the rapidly expanding fields of RNA therapeutics and cell-based immunotherapies. "This project has the potential to generate significant scientific and translational impact by advancing non-viral technologies for immune cell engineering and addressing important limitations associated with conventional CAR-T cell therapies. The development of nanoparticle-based approaches for delivering CAR-encoding self-amplifying RNA could contribute to simpler, more adaptable and potentially more cost-effective strategies for engineering therapeutic T cells. Although the primary disease focus will be glioblastoma, the knowledge and technologies generated may have broader applications in cancer immunotherapy and other immune-mediated diseases. The project is expected to generate research outputs suitable for publication in peer-reviewed scientific journals and presentation at national and international conferences in nanomedicine, drug delivery, RNA therapeutics and cancer immunotherapy. These activities will facilitate knowledge exchange, increase research visibility and establish opportunities for interdisciplinary and international collaborations. The student will also be encouraged to participate in public engagement and outreach activities, communicating the potential of RNA-based medicines and emerging cancer immunotherapies to non-specialist audiences. Overall, the project will contribute to strengthening research capacity in RNA nanomedicine and advanced therapeutics at Queen's University Belfast, while providing a foundation for future translational research, collaborative funding applications and the development of innovative therapeutic technologies."

Funding Information

This PhD project is supported by a fully funded Department for the Economy (DfE) studentship, covering tuition fees and an annual maintenance stipend in accordance with DfE funding rates and eligibility criteria. The studentship also provides access to research training and professional development opportunities at Queen's University Belfast. Open to UK& ROI students. Projects will run subject to approval from the Department for the Economy

Dr Flávia Sousa

Full-time: 3 years

Pharmacy overview

The School of Pharmacy (SoP) focuses its research activities on key areas of the pharmaceutical sciences, clinical and primary care aspects of pharmacy. Our research spans a wide range of scientific and professional disciplines. Multidisciplinary sits at the core of many of our internationally-connected research programmes, ultimately delivering impactful research designed to benefit patients. The School of Pharmacy is committed to research excellence. This is achieved through ambitious target setting, a key feature of our School Strategy, feeding into the broader University Strategy 2030. We will continually strive for research excellence, strategic recruitment and encourage/enable impactful internal and external collaborations. The SoP has as a broad portfolio of high quality research income and staff within the School publish widely in leading journals and present their work at national and international conferences. Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice. Research programmes are grouped into five key themes, which are mainly funded by UK/European Government sources, leading medical charities and importantly the pharmaceutical industry. 1. NANOMEDICINE AND BIOTHERAPEUTICS This area focus on the development of novel technologies and targeted therapies for advanced healthcare solutions including anticancer therapeutics, nanoparticles and nano-delivery of macromolecules; proteases in disease and natural peptides. http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/NanomedicineandBi 2. PHARMACEUTICAL MATERIALS SCIENCE AND FORMULATION This activity centres on the design, development and industrial translation of novel systems for patient-focused administration of difficult-to-deliver drugs including; HIV prevention and multipurpose prevention technologies; solid dosage forms and microneedles. http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/PharmaceuticalMate 3. DRUG DELIVERY AND BIOMATERIALS The area investigates the development of materials which interface with the body, providing enhanced functionality. Applications include improved drug delivery, infection resistance or monitoring of levels of drug or host markers. The three main areas are: photoactive biomaterials, polymeric medical devices and sensor development. http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/DrugDeliveryandBio 4. INFECTION AND ANTIMICROBIAL RESISTANCE This research theme consists of both basic and clinical research to improve the prevention, detection and treatment of infection, in particular for respiratory infectious diseases, antimicrobial stewardship and novel antimicrobials and anti-infective biomaterials http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/InfectionandAntimicr 5. HEALTHCARE DELIVERY AND MEDICINES OPTIMISATION Reaearch within heath care delivery and medicines optimisation encompasses the development and implementation of interventions that improve the health outcomes for patients in primary and secondary care. This includes systems of healthcare delivery; quality of care in vulnerable populations and clinical paediatrics https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/HealthcareDeliveryandMedicinesOptimisation/

  • The Graduate School is a dedicated, University wide facility designed to connect postgraduate students from across all disciplines. It is located on the main site, within the recently renovated Lynn Library. The Graduate School provides an array of valuable training opportunities, tailor built to meet the needs of our postgraduate community. Importantly, courses are designed to provide support for core generic skills and for subject specific topics. Additionally, areas with the Graduate School can be reserved by postgraduate providing an idyllic retreat for those times which require intense focus. More information about the Graduate School, can be found below: https://www.qub.ac.uk/graduate-school/
  • These unique research programmes are delivered by numerous leading international academic experts in specialist fields including drug delivery, medical devices and nanotechnology. Details of specific staff, with links to their areas of research expertise can be located below: https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/
  • 89% of current PhD students with the School of Pharmacy agree that the supervisory support and feedback equips them with the knowledge and experience to complete their research degree (PRES 2021).

Course content

Associated Research School of Pharmacy works closely with both local and global pharmaceutical companies. This ensures a successful pipeline for the development of novel emerging healthcare technologies, designed specifically to deliver patient benefit.

Research Themes NANOMEDICINE AND BIOTHERAPEUTICS Research in this theme is focused on the development of novel technologies and targeted therapies for advanced healthcare solutions. Activities are concentrated on the development of unique genetic therapies and delivery systems that can be applied for the detection and treatment of various disease condition, design and commercial translation of novel nanomedicines with a focus on cancer treatment, the detection, characterisation and inhibition of proteases implicated in chronic diseases, the isolation and characterisation of bioactive peptides for potential therapeutic use and computational biology for drug design and molecular modelling.

Research Themes PHARMACEUTICAL MATERIALS SCIENCE AND FORMULATION Research in this theme is focused on the design, development and industrial translation of novel systems for patient-focused administration of difficult-to-deliver drugs. Activities are concentrated on the development of formulations to address major global issues around sexual and reproductive health, use of hot melt granulation and polymer extrusion/injection moulding technologies to produce solid dosage forms, multi-layered and targeted drug delivery systems, the use microneedles for transdermal drug delivery, patient monitoring and vaccine delivery, implantable delivery systems and ocular therapeutics.

Research Themes DRUG DELIVERY AND BIOMATERIALS Research in this theme is focused on the development of materials which interface with the body and provide enhanced functionality, such as drug delivery, infection resistance or monitoring of levels of drug or host markers. Activities are concentrated on the development of new methods for fabricating materials for medical device manufacture including biomaterials with enhanced anti-infective and biocompatibility properties. Sensor research focuses on sensors immobilised in biocompatible scaffolds, blood-free diagnosis/patient monitoring using microneedles and developing point-of-care tests for microbial infection.

Research Themes INFECTION AND ANTIMICROBIAL RESISTANCE Research in this theme is focused on improved prevention, detection and treatment of infection. Activities are concentrated on preventing the development of antimicrobial resistance through improved antimicrobial stewardship, improved detection of infection using molecular and sensor based technology, prevention of infection using novel anti-infective biomaterials and enhanced infection prevention and control strategies and improved treatment of infection through discovery of novel antibiotics and antibiotic adjuvants and markers for better evidence-based decisions on antibiotic selection.

Research Themes HEALTHCARE DELIVERY AND MEDICINES OPTIMISATION Research in this theme is focused on the development and implementation of interventions that improve the health outcomes of patients in primary and secondary care. Activities are concentrated on improving systems of patient care in all health care sectors with a focus on the appropriateness of prescribing in chronic disease and in care home residents with dementia, and medication adherence in children.

Research Themes The School of Pharmacy at Queen’s is widely acknowledged as a leading centre for Pharmacy teaching and research in the UK. We are currently ranked 2nd School of Pharmacy in the UK for Pharmacy and Pharmacology Research (The Complete University Guide 2022) PhD opportunities are available in: •Nanomedicine and biotherapeutics •Pharmaceutical materials science and formulation •Drug delivery and biomaterials •Infection and antimicrobial resistance •Healthcare delivery and medicines optimisation

Research Success The research profile produced by the 2021 UK Research Excellence Framework (REF) showed that 97% of the research outputs with our combined Allied Health Professions, Dentistry, Nursing and Pharmacy submission fell within the highest quality 4 and 3 categories, with 51% classed as world-leading 4 research, confirming our reputation as an internationally-leading research centre. Excellence across the School of Pharmacy is evidenced by our consistent ranking as one of the top pharmacy schools within the UK. We are very proud that in 2022 our School was ranked by the QS World Rankings in the top 15% (55th) globally for Pharmacy and Pharmacology.

Research Themes Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice. REF 2021 showed that 97% of the School’s submitted research fell within the highest quality 4 and 3 categories, with 43% classed as world- leading 4 research. The School of Pharmacy has a long-standing track record in undertaking research which has had impact on healthcare and wellbeing for the population. Our work has led to the development of a local anaesthetic cream formulation, the creation of several spin-out companies (e.g. ProAxsis, pHion Therapeutics, Re-Vana Therapeutics), devices to help prevent the spread of HIV and a new type of pharmacy-led service which improves the prescribing of medication for older people. We constantly strive to do research which will positively impact society and improve the delivery of health care. One example of our high impact research includes the BREATH project led by Professor Lorraine Martin (https://www.breath-copd.org).

Research Projects Materials & Advanced Technologies for Healthcare (MATCH) is an interdisciplinary research initiative comprising leading researchers from the Schools of Pharmacy, Chemistry & Chemical Engineering, Mechanical and Aerospace Engineering, Biological Sciences, Medicine, Dentistry & Biomedical Sciences and Nursing & Midwifery. Our research is based on one key question: “How can we use advanced technologies to significantly improve healthcare outcomes?” We connect researchers along the development pathway and follow a unique “Molecule to Patient” approach. Currently, single-stranded strategies are applied to development and use of new healthcare products. Without a holistic approach, medicines are wasted, patients suffer avoidable adverse effects, or go untreated. Greater interaction between those involved in identifying novel therapeutic targets, drug discovery, materials science, pharmaceutical formulation, manufacture, diagnosis, prescribing and medicines utilisation is a significant unmet need. If addressed, this stands to have major impact in the care of all patients, but especially the very young and old, representing the populations in which medicines may present the greatest risk, but have maximum benefit. We take an innovative dual approach, firstly by developing the underpinning technologies, secondly by exploiting the possibilities that these technologies present to maximum clinical and commercial advantage by selecting the best target areas and understanding patient factors.

Introduction Many of our PhD graduates have moved into academic and research roles in Higher Education while others go on to play leading roles within the pharmaceutical industry. Queen's postgraduates reap exceptional benefits from facilities within the School, but also from wider University initiatives, such as Degree Plus and Researcher Plus, both of which bolster candidate employability.

Employment after the Course Queen’s University offer extensive career development opportunities to PhD students. Further details can be accessed via the link below. https://www.qub.ac.uk/directorates/sgc/careers/

Dr Heather Barry PGR Director Pharmacy Applications considered throughout the year from applicants who have secured external funding or are willing to self-fund the project.

Students will be expected to present drafts of their work at regular intervals to their supervisor who will provide written and oral feedback; a formal assessment process takes place annually, termed the Annual Progress Review (APR). APR requires students to present their work in both the written and oral format to a panel of academics from within the School. Successful completion of this process will allow students to register for the next academic year. Students will be expected to present drafts of their work at regular intervals to their supervisor who will provide written and oral feedback; a formal assessment process takes place annually, termed the Annual Progress Review (APR). APR requires students to present their work in both the written and oral format to a panel of academics from within the School. Successful completion of this process will allow students to register for the next academic year. The final assessment of the doctoral degree is both written and oral. Students will submit their thesis to an internal and external examining team who will review the written thesis before inviting the student to orally defend their work at a Viva Voce.

Supervisors will offer feedback on draft work at regular intervals throughout the period of registration on the degree.

Full time PhD students will have access to a shared office space and access to a desk with personal computer and internet access.

Entrance requirements

Graduate The minimum academic requirement for admission to a research degree programme is normally an Upper Second Class Honours degree from a UK or ROI HE provider, or an equivalent qualification acceptable to the University.

For information on international qualification equivalents, please check the specific information for your country .

Evidence of an IELTS score of 6.0, with not less than 6.0 in writing, and not less than 5.5 in listening, speaking and reading, or an equivalent qualification acceptable to the University is required. Taken within the last 2 years.

International students wishing to apply to Queen's University Belfast (and for whom English is not their first language), must be able to demonstrate their proficiency in English in order to benefit fully from their course of study or research. Non-EEA nationals must also satisfy UK Visas and Immigration (UKVI) immigration requirements for English language for visa purposes.

For more information on English Language requirements for EEA and non-EEA nationals see: www.qub.ac.uk/EnglishLanguageReqs .

If you need to improve your English language skills before you enter this degree programme, INTO Queen's University Belfast offers a range of English language courses. These intensive and flexible courses are designed to improve your English ability for admission to this degree.

Tuition Fees

Northern Ireland (NI) 1 | TBC

Republic of Ireland (ROI) 2 | TBC

England, Scotland or Wales (GB) 1 | TBC

EU Other 3 | £28,900

International | £28,900

1 EU citizens in the EU Settlement Scheme, with settled or pre-settled status, are expected to be charged the NI or GB tuition fee based on where they are ordinarily resident, however this is provisional and subject to the publication of the Northern Ireland Assembly Student Fees Regulations. Students who are ROI nationals resident in GB are expected to be charged the GB fee, however this is provisional and subject to the publication of the Northern Ireland Assembly student fees Regulations.

2 It is expected that EU students who are ROI nationals resident in ROI will be eligible for NI tuition fees. The tuition fee set out above is provisional and subject to the publication of the Northern Ireland Assembly student fees Regulations.

3 EU Other students (excludes Republic of Ireland nationals living in GB, NI or ROI) are charged tuition fees in line with international fees.

All tuition fees quoted relate to a single year of study unless stated otherwise. All fees will be subject to an annual inflationary increase, unless explicitly stated otherwise.

More information on postgraduate tuition fees .

Pharmacy costs

Additional course costs

Depending on the programme of study, there may also be other extra costs which are not covered by tuition fees, which students will need to consider when planning their studies . Students can borrow books and access online learning resources from any Queen's library. If students wish to purchase recommended texts, rather than borrow them from the University Library, prices per text can range from £30 to £100. Students should also budget between £30 to £100 per year for photocopying, memory sticks and printing charges. Students may wish to consider purchasing an electronic device; costs will vary depending on the specification of the model chosen. There are also additional charges for graduation ceremonies, and library fines. In undertaking a research project students may incur costs associated with transport and/or materials, and there will also be additional costs for printing and binding the thesis. There may also be individually tailored research project expenses and students should consult directly with the School for further information.

Some research programmes incur an additional annual charge on top of the tuition fees, often referred to as a bench fee. Bench fees are charged when a programme (or a specific project) incurs extra costs such as those involved with specialist laboratory or field work. If you are required to pay bench fees they will be detailed on your offer letter. If you have any questions about Bench Fees these should be raised with your School at the application stage. Please note that, if you are being funded you will need to ensure your sponsor is aware of and has agreed to fund these additional costs before accepting your place.

How do I fund my study?

Find PhD opportunities and funded studentships by subject area.

We offer numerous opportunities for funded doctoral study in a world-class research environment. Our centres and partnerships, aim to seek out and nurture outstanding postgraduate research students, and provide targeted training and skills development.

The Government offers doctoral loans of up to £26,445 for PhDs and equivalent postgraduate research programmes for English- or Welsh-resident UK and EU students.

Information on Postgraduate Research scholarships for international students .

The Funding & Scholarship Finder helps prospective and current students find funding to help cover costs towards a whole range of study related expenses.

How to Apply

Apply using our online Postgraduate Applications Portal and follow the step-by-step instructions on how to apply .

If you're interested in a particular project, we suggest you contact the relevant academic before you apply, to introduce yourself and ask questions.

To find a potential supervisor aligned with your area of interest, or if you are unsure of who to contact, look through the staff profiles linked here .

You might be asked to provide a short outline of your proposal to help us identify potential supervisors.

Download Postgraduate Prospectus

Research areas

Pharmaceutical Nanotechnologymolecular biologyMolecular biologyMolecular BiologyRNA therapeuticsNanotechnologyImmunotherapyBiology

Related PhD opportunities